The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650M in funding for the CDMRP. Congress provided further guidance for CDMRP program-level funding, including funding for the Prostate Cancer Research Program. The FY25 PCRP intends to support innovative, high-impact prostate cancer research.
The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650M in funding for the CDMRP.
The National Institute for Health Care Management Foundation is now accepting letters of inquiry for the 2025-2026 funding cycle of NIHCM Foundation’s Research Grant program. We will be awarding a total of $500,000 in grants to support innovative, independent, investigator-initiated research that has the potential to inform managed care organizations, policymakers, and related stakeholders to improve the affordability and quality of U.S. health care.
The Maryland Stem Cell Research Commission awarded over $18 million in grants aimed at accelerating cutting-edge stem cell and regenerative medicine research across Maryland.
The Full-Year Continuing Appropriations and Extensions Act of 2025 provides $650 million in funding for the Congressionally Directed Medical Research Programs (The Cancer Letter, March 28, 2025). Congress provided further guidance for CDMRP program-level funding, including funding for the Rare Cancers Research Program.
The American Association for Cancer Research has established the AACR Trailblazer Cancer Research Grant Program.
The American Association for Cancer Research-Novocure Career Development Award for Cancer Research represents a joint effort to promote and support early-career investigators who are conducting innovative research focused on Tumor Treating Fields (TTFields; intermediate frequency, low intensity, alternating electric fields that disrupt cell division in cancer cells) as well as to encourage early-career investigators to enter the TTFields research field.
The Stephenson Global Pancreatic Cancer Research Institute, established to advance early detection, innovative treatments, and groundbreaking research for pancreatic cancer, has launched a call for nominations and Letters of Intent for two award opportunities.
Global research initiative Cancer Grand Challenges announced on March 5 seven new challenges which it deems to be among the biggest questions in cancer, offering international researchers the chance to form teams to apply for up to $25 million (or £20 million) in funding to take them on.
The FY25 Defense Appropriations Act is anticipated to provide funding for the Peer Reviewed Cancer Research Program to support innovative, high-impact cancer research.
